Latest 8-K filings

Corteva, Inc. has successfully completed the separation of its seed operating segment into a new independent, publicly traded company named Vylor Inc.

First Merchants Corporation announced the upcoming retirement of CEO Mark Hardwick, effective January 1, 2027, with President Mike Stewart set to assume the CEO role.

Azitra, Inc. announced its Phase 1/2 clinical trial for ATR-04 in treating EGFR inhibitor-associated skin rash will proceed to Cohort 2 following a positive safety review.

Aptera Motors announced a substantial reduction in its estimated capital requirements for production, driven by a strategic partnership with Launch Design.

Airgain, Inc. announced the appointment of Stephan D. Memmen to its Board of Directors, effective October 1, 2026, expanding the board to eight members.

Evommune presented compelling Phase 2a data for EVO301 in atopic dermatitis, demonstrating significant efficacy and a favorable safety profile, with plans for a Phase 2b trial in mid-2027.

Strategy Inc. announced the maintenance of its Variable Rate Series A Perpetual Stretch Preferred Stock dividend rate at 12.00% and detailed a conditional dividend payment structure contingent on a shareholder vote.

Allarity Therapeutics announced significant advancements in its Drug Response Predictor (DRP) technology, patent portfolio, and laboratory capabilities, reinforcing the clinical development of stenoparib and opening avenues for external partnerships.

Radnostix Inc. has signed a definitive agreement to divest its depleted uranium hexafluoride (DUF6) deconversion and fluorine extraction assets, including a U.S. Nuclear Regulatory Commission (NRC) license, to Nano Nuclear Energy Inc. for $9.5 million in cash and $4.0 million in stock.

Nektar Therapeutics announced new long-term data from its Phase 2b REZOLVE-AA and REZOLVE-AD studies for rezpegaldesleukin, showcasing durability and disease improvement in alopecia areata and atopic dermatitis patients.

USA Rare Earth announced the completion of its CEO succession plan, with Thras Moraitis assuming the CEO role to focus on integration, execution, and growth.

Armada Acquisition Corp. II shareholders overwhelmingly approved the business combination proposal and related matters at an extraordinary general meeting, paving the way for the proposed transactions.

Veritone, Inc. announced a $15 million registered direct offering of common stock to repay convertible debt and for general corporate purposes.

Toast, Inc. announced that Chief Revenue Officer Jonathan Vassil will retire effective December 31, 2026, transitioning to a non-executive role until April 2027.

Brightline Interactive announced the successful closing of a private investment round, raising $1.25 million to fuel platform development and market expansion.

Valion Bio and Shear Kershman Laboratories have successfully completed formulation work for an oral mucosal Entolimod delivery system, potentially expanding its application beyond injections.

Corteva, Inc. announced the final results of its private exchange offers and consent solicitations for EIDP Notes, with settlement expected to occur concurrently with its planned separation.

Corteva, Inc. announced the final results of its private exchange offers and consent solicitations for EIDP Notes, with settlement expected to occur concurrently with its planned separation.

Monte Rosa Therapeutics announced positive Phase 1 results for its investigational drug MRT-8102, demonstrating normalization of key pathogenic drivers of ASCVD and a favorable safety profile, with plans for Phase 2 trials in multiple indications.

Installed Building Products announced the release of its 2026 Environmental, Social, and Governance (ESG) report, detailing progress in sustainability, employee well-being, and community engagement.

McCormick & Company announced solid third quarter 2026 results, with net sales up 17.4% and adjusted gross profit margin expansion, while reaffirming its full-year financial outlook.

Chesapeake Utilities Corporation announced an at-the-market equity offering program to raise up to $225 million in common stock to fund general corporate purposes.

Kyntra Bio announced the appointment of Andrew E. Singer to its Board of Directors and the renewal of CEO Thane Wettig's Change in Control and Severance Agreement.

FrontView REIT announced third quarter investment activity, acquiring 16 properties for $50.6 million and selling 5 properties for $17.1 million, alongside capital markets transactions including equity sales and preferred stock issuance.

Civista Bancshares, Inc. announced the appointment of Mark J. Sams as Senior Vice President and Chief Revenue Officer, effective October 1, 2026.

Acuity Inc. announced fiscal 2026 fourth-quarter and full-year results, showcasing net sales growth, improved operating performance, and strong cash flow.

Slam Corp. has amended and restated its consolidated promissory note with its sponsor, consolidating $15.5 million in debt, introducing interest, and terminating a warrant conversion right.

Keurig Dr Pepper Inc. announced the appointment of Russ Torres as CEO of the future Global Coffee Co., effective November 3, 2026, ahead of the planned separation of its coffee and beverage businesses.

Kimberly-Clark Corporation announced the departure of its President and Chief Operating Officer, Russell Torres, effective November 2, 2026, as he seeks other opportunities.

Fervo Energy announced commercial operation at its Cape Station in Utah, marking a global first for enhanced geothermal systems and generating revenue ahead of schedule.